bisindolylmaleimide i has been researched along with stilbenes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Giembycz, MA; Lindsay, MA; Lynch, OT | 1 |
Bhavaraju, K; Daniel, JL; Kim, S; Kunapuli, SP | 1 |
2 other study(ies) available for bisindolylmaleimide i and stilbenes
Article | Year |
---|---|
Pharmacological comparison of LTB(4)-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils.
Topics: Androstadienes; Animals; Antibodies; Carbazoles; CD18 Antigens; Cell Adhesion; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Enzyme Precursors; Eosinophils; Flavonoids; Guinea Pigs; Imidazoles; Indoles; Integrin beta1; Intracellular Signaling Peptides and Proteins; Leukotriene B4; Macrophage-1 Antigen; Male; Maleimides; Mitogen-Activated Protein Kinases; NADPH Oxidases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Protein-Tyrosine Kinases; Pyrazoles; Pyridines; Pyrimidines; Rats; src-Family Kinases; Stilbenes; Syk Kinase; Time Factors; Wortmannin | 2001 |
Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.
Topics: Adaptor Proteins, Signal Transducing; Blood Platelets; Blotting, Western; Crotalid Venoms; Cytoplasmic Granules; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Lectins, C-Type; Maleimides; Membrane Proteins; Oligopeptides; Phospholipase C gamma; Phosphorylation; Platelet Function Tests; Protein Kinases; Protein-Tyrosine Kinases; Signal Transduction; src-Family Kinases; Stilbenes; Sulfonamides; Syk Kinase; Thromboxanes; Tyrosine | 2008 |